Other languages Global Cord Blood Corporation

Equities

CORBF

KYG393421030

Market Closed - OTC Markets Other stock markets 01:03:43 04/05/2024 am IST			5-day change	1st Jan Change
1.25 ^USD	0.00%		0.00%	+2.46%

2023	Global Cord Blood Corporation Announces Board Appointments	CI
2023	Global Cord Blood Corporation(NYSE:CO) dropped from S&P Global BMI Index	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Global Cord Blood Corporation Announces Board Appointments	30/23/30
Global Cord Blood Corporation Announces Board Changes	18/23/18
China Cord Blood Posts Lower Fiscal Q4 Profit, Revenue	06/22/06
Global Cord Blood Corporation Reports Earnings Results for the Full Year Ended March 31, 2022	06/22/06
Global Cord Blood Corporation Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	06/22/06
Global Cord Says Cellenkos Gets US FDA OK of IND Application for CK0804 as Add-on Therapy to Ruxolitinib for Myelofibrosis	17/22/17
Global Cord Blood Corporation Approves Board Changes	17/22/17
Global Cord Blood Shareholder Blue Ocean Says EGM Called to Vote on Cellenkos Deal Cancelation Proposal	04/22/04
Global Cord Blood Corporation Proposes Board Changes	03/22/03
Global Cord Blood Corporation (NYSE:CO) cancelled the acquisition of an unknown stake in Cellenkos, Inc. from Leong Kim Chuan.	20/22/20
Blue Ocean Structure Provides Information to Shareholders of Global Cord	13/22/13
Blue Ocean Structure Investment Company Limited Communicates with Global Cord Blood Corporation	13/22/13
Blue Ocean Structure Investment Company Limited Sues Global Cord Blood Corporation	09/22/09
China Cord Blood's Stock Down 35%; Announces Acquisition of Cellenkos	02/22/02
Global Cord Blood Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	01/22/01
Health Care Stocks Point Lower Premarket Friday	17/21/17
Global Cord Blood Rejects Takeover Bid From Alternate Ocean Investment	17/21/17
Global Cord Blood Corporation Posts Lower Q2 Profit Amid Higher Revenue -- Stock Up 2% After-Hours	25/21/25
Global Cord Blood Corporation Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	29/21/29
Global Cord Blood : China Cord Blood Receives $5 per Share Takeover Bid From Haitong International Securities Group Unit	02/21/02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Global Cord Blood Corporation

Equities

CORBF

KYG393421030

Other languages

Filters